WO2019175739A1 - Aliments pour l'amélioration de la santé et des performances de mammifères - Google Patents

Aliments pour l'amélioration de la santé et des performances de mammifères Download PDF

Info

Publication number
WO2019175739A1
WO2019175739A1 PCT/IB2019/051941 IB2019051941W WO2019175739A1 WO 2019175739 A1 WO2019175739 A1 WO 2019175739A1 IB 2019051941 W IB2019051941 W IB 2019051941W WO 2019175739 A1 WO2019175739 A1 WO 2019175739A1
Authority
WO
WIPO (PCT)
Prior art keywords
high intensity
feed
intensity sweetener
mammals
ppm
Prior art date
Application number
PCT/IB2019/051941
Other languages
English (en)
Inventor
Emma WALL
Original Assignee
Pancosma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pancosma Sa filed Critical Pancosma Sa
Priority to EP19715223.4A priority Critical patent/EP3764817A1/fr
Priority to CN201980013368.2A priority patent/CN111867400A/zh
Publication of WO2019175739A1 publication Critical patent/WO2019175739A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/50—Feeding-stuffs specially adapted for particular animals for rodents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents

Definitions

  • This invention relates to feeds and feed additives containing a high intensity sweetener and/or capsicum oleoresin and their use to improve health and performance of mammals.
  • Enteritis is an infection of the digestive tract that can be caused by a variety of different pathogens. In rabbits, enteritis is a devastating disease that accounts for the majority of illnesses, deaths, and economic losses. Young and recently-weaned rabbits are especially susceptible and the primary symptom is diarrhea, combined with a decrease in growth and performance. Colibacillosis is enteritis caused by the bacterial pathogen Escherichia coli (E. Coii), which in rabbits infects both the small intestine and the cecum. Colibacillosis is very common in young rabbits and mortality rates can be very high; the disease can be passed from the doe to the kits with often the entire litter impacted by the sickness.
  • E. Coii bacterial pathogen Escherichia coli
  • Phytonutrients are naturally-occurring bioactive chemicals found in plants. In monogastric species, supplementation of the feed with the phytonutrient capsicum oleoresin has been shown to mitigate oxidative stress (Karadas et al., 2014. Br Poult Sci. 55: 329-334) and prevent disease symptoms (Liu et al ., 2012. J Anim Sci. 90: 2774-2783, Lee et al., 2013. Br J Nutr. 110: 840-847, Liu et al., 2013. J Anim Sci. 91: 5668-5679, Liu et al., 2013. J Anim Sci. 91: 5294-5306) by enhancing immunity.
  • Capsicum oleoresin has also been shown to improve gut health during normal and disease conditions (Liu et al., 2014. J Anim Sci. 92: 3426-3440, Liu et al., 2014. J Anim Sci. 92: 2050-2062).
  • GLP-2 glucagon-like peptide
  • the effective doses vary but normally range between 20 and 400 ppm for phytonutrients and >200 ppm for high intensity artificial and natural sweeteners (Moran et al., 2010. Br J Nutr. 104: 637-646, Moran et al., 2014. J Dairy Sci. 97: 4955-4972, Ponce et al., 2014. J Anim Sci. 92: 1630- 1638, Siurana et al., 2014. J. Dairy Sci. 97 (E-Suppl. 1): 811 (Abstr.), Connor et al., 2017. J Dairy Sci. 100: 3004-3018). Often even higher doses of these molecules are used especially for phytonutrients which are often used for their anti-microbial properties. The doses used depend on the species, molecules tested and the objectives of the study.
  • the challenge addressed in the current invention is to improve the health and performance of mammals, in particular rabbits, without the use of antibiotics.
  • the inventors explored the use of high intensity artificial and natural sweetener or capsicum oleoresin fed alone and in combination.
  • doses that have previously been established as beneficial in other species are in fact highly detrimental in rabbits.
  • the current invention therefore introduces a novel approach using additives to decrease the negative impact of enteritis in rabbits.
  • a combination of the two additives is used for synergistic effects on health (decreased morbidity - including diarrhea and bloat - and mortality) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of rabbits.
  • a range of specific ratios of high intensity sweetener to capsicum oleoresin is used for synergistic effects on health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of rabbits.
  • a combination of high intensity sweetener and capsicum oleoresin when supplemented at very low doses, improves zootechnical performance of other mammals including calves and piglets.
  • the invention relates to a feed including:
  • At least one artificial high intensity sweetener in an amount greater than zero and less than or equal to 50 ppm; or - at least one natural high intensity sweetener in an amount greater than zero and less than or equal to 180 ppm.
  • the invention pertains to a feed including capsicum oleoresin in an amount greater than zero and less than or equal to 2 ppm.
  • the invention relates to a feed additive including at least one high intensity artificial or natural sweetener and capsicum oleoresin, wherein the weight ratio of high intensity sweetener to capsicum oleoresin is less than 100:1 and preferably less than or equal to 25:1.
  • SW artificial high intensity sweetener
  • SWN natural high intensity sweetener
  • CO capsicum oleoresin
  • SW artificial high intensity sweetener
  • SWN natural high intensity sweetener
  • CO capsicum oleoresin
  • SWN high intensity sweetener
  • CO capsicum oleoresin
  • Figure 4 illustrates that an optimal weight ratio between natural high intensity sweetener (SWN) and capsicum oleoresin (CO) is shown by a linear decrease in morbidity in rabbits inoculated with Escherichia coli.
  • Figure 7 shows that a supplement including natural high intensity sweetener (SWN) at 26 ppm and capsicum oleoresin (CO) at 2 ppm is efficient at decreasing veterinary treatments in calves.
  • SWN natural high intensity sweetener
  • CO capsicum oleoresin
  • Figure 8 shows that a supplement including natural high intensity sweetener (SWN) at 30 ppm and capsicum oleoresin (CO) at 2 ppm is efficient at increasing body weight in piglets.
  • SWN natural high intensity sweetener
  • CO capsicum oleoresin
  • feed additive is herein meant an additive which is not aimed at being used alone but added to the usual ingredients of a conventional feed of the mammal.
  • final feed is herein meant the feed obtained after the addition of the feed additive of the invention and ready to be fed to the mammal.
  • This invention proposes a novel approach for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) in mammals including rabbits, swine, and calves by using low doses of a high intensity sweetener, capsicum oleoresin, or a combination of the two.
  • This invention may be used during normal rearing conditions or during phases where enteritis may be present.
  • enteritis By enteritis, the inventors refer to any inflammation of the gastrointestinal tract of mammals, no matter what the causative agent (including but not limited to: coccidiosis, enterotoxemia, colibacillosis, mucoid enteritis, proliferative enteropathy, or Tyzzer's disease).
  • the high intensity sweetener can be a high intensity artificial sweetener, a high intensity natural sweetener, or their combinations.
  • the high intensity artificial sweetener used for this invention may include and is not limited to: saccharin and its salts, acesulfame-K, cyclamate, aspartame, sucralose, neotame, advantame alone or in combination.
  • the high intensity artificial sweetener may also include a potentiator.
  • the high intensity artificial sweetener includes at least 96wt% sodium saccharinate, and at least 0.2wt% neohesperidin dihydrochalcone (NH DC).
  • the dose of artificial high intensity sweetener used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) in rabbits includes all doses that are ⁇ 50 ppm in the final feed.
  • the high intensity natural sweetener used for this invention may include and is not limited to: stevia leaf, stevia extracts, steviosides including steviol glycosides, rebaudioside A, rebaudioside C, dulcoside A, rubusoside, steviolbiosode, rebaudioside B, or any other high intensity sweetener from natural origin alone or in combination.
  • the high intensity sweetener from natural origin can also originate from the flowing plants and/or their extracts and/or active compounds: Pentadiplandra brazzeana (pentadina and brazzein), lllicium verum, Piper marginatum or Myrrhis odorata (trans-anethole and estragole), Osmorhiza longistylis (anethole), Citrus paradis (naringin), Hydrangea macrophylla (dihydro-coumarin).
  • the high intensity natural sweetener may also include a potentiator.
  • the high intensity natural sweetener used includes at least 75wt% steviol glycosides (at least 25wt% of which was rebaudioside A), and also a potentiator: at least 0.3wt% ammonium glycyrrhizinate.
  • the potentiator included in the high intensity artificial or natural sweetener may be selected from the list including but not limited to: glycyrrhizin, ammonium glycyrrhizinate, potassium glycyrrhizinate, sodium glycyrrhizinate, thaumatin, kokumi, NHDC, ribotides, sodium glutamate.
  • very low doses of high intensity natural sweetener were discovered to be beneficial for health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of rabbits.
  • the inventors first tested a dose that made sense based on the state of the art as this dose had been previously established as beneficial for other small mammals (360 ppm in the feed). Surprisingly, the inventors found that in rabbits this dose was highly detrimental because it greatly increased mortality during an enteritis challenge. Next, the inventors tested a new lower dose of 180 ppm supplemented to rabbits, followed by an enteritis challenge and it was discovered that mortality was greatly reduced at this low dose.
  • the dose of high intensity natural sweetener used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth and feed efficiencies) in rabbits includes all doses that are ⁇ 200 ppm and preferably ⁇ 180 in the final feed.
  • the capsicum used for this invention may include and is not limited to: capsicum oleoresin that is plant- derived (natural) or any product containing at least 6wt% capsaicinoids (capsaicin and dihydrocapsaicin).
  • capsicum oleoresin was supplemented as a product that was manufactured using capsicum oleoresin (22wt%) incorporated into a matrix of 78wt% rape seed oil (via spray cooling), the method that is described in document EP2088871 (US20100055253; W02008062368).
  • the final encapsulated product contained 20wt% capsicum oleoresin.
  • capsicum oleoresin were discovered to be beneficial for health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of rabbits.
  • the inventors first tested a dose (4 ppm in the feed) that had been previously established as beneficial for other small mammals, and found that in rabbits it was detrimental because it increased mortality during an enteritis and/or colibacillosis challenge.
  • the inventors tested a new lower dose of 2 ppm supplemented to rabbits, followed by an enteritis challenge and it was discovered that mortality was greatly reduced at this low dose.
  • the dose of capsicum oleoresin used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) in rabbits includes all doses that are ⁇ 2 ppm in the final feed.
  • the dose of a mixture of high intensity sweetener and capsicum oleoresin used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) in rabbits includes all doses that are ⁇ 200 ppm and preferably ⁇ 180 ppm of high intensity sweetener and ⁇ 2 ppm of capsicum oleoresin in the final feed (weight ratio of high intensity sweetener: capsicum oleoresin ⁇ 100:1 and preferably ⁇ 25:1).
  • the dose of a mixture of high intensity artificial sweetener and capsicum oleoresin used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) in rabbits includes all doses that are ⁇ 100 ppm and preferably ⁇ 50 ppm of high intensity artificial sweetener and ⁇ 2 ppm of capsicum oleoresin in the final feed (weight ratio of high intensity artificial sweetener: capsicum oleoresin ⁇ 50:1 and preferably ⁇ 25:1).
  • the inventors then tested the use of such low doses of high intensity sweetener and capsicum oleoresin fed in combination to other mammals including swine and calves. In both cases, the low doses fed improved digestive health and zootechnical performance.
  • the dose of a mixture of high intensity natural sweetener and capsicum oleoresin used in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of mammals includes all doses that are ⁇ 200 ppm and preferably ⁇ 180 ppm of high intensity natural sweetener and ⁇ 2 ppm of capsicum oleoresin in the final feed (weight ratio of high intensity artificial sweetener: capsicum oleoresin ⁇ 100:1 and preferably ⁇ 25:1).
  • the examples provided in this invention include weight ratios of natural high intensity sweetener: capsicum oleoresin of 12.5:1, 45:1, 90:1 (Example 2), 11.5:1 (Example 3), 13:1 (Example 4) and 15:1 (Example 5).
  • the product including high intensity sweetener and capsicum oleoresin that was created in this invention contains up to 66wt% stevia extract (comprising at least 75wt% steviol glycosides of which at least 25wt% is rebaudioside A) and up to 3wt% capsicum oleoresin (containing at least 6wt% capsaicinoids (capsaicin and dihydrocapsaicin)).
  • the final product includes >49wt% steviol glycosides, >12wt% rebaudioside A, and >0.18wt% capsaicinoids. It also includes up to 3wt% NHDC and up to 3wt% Glycyrrhizin NH 3 .
  • the product may include some technological agents such as arabic gum, modified starch, maltodextrin, etc.
  • the product can be obtained via standard atomization technologies (e.g. fluidized bed spray granulation, spray drying, etc.).
  • the effective dose of the product including high intensity sweetener and capsicum oleoresin that was created in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of mammals includes all doses that are ⁇ 100 ppm in the final feed.
  • the effective dose of the product including high intensity artificial sweetener and capsicum oleoresin that was created in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of mammals includes all doses that are ⁇ 100 ppm in the final feed.
  • the effective dose of the product including high intensity natural sweetener and capsicum oleoresin that was created in this invention for improving health (decreased mortality - including diarrhea and bloat - and morbidity) and performance (increased intake, daily gains and/or improved growth or feed efficiencies) of mammals includes all doses that are ⁇ 100 ppm in the final feed.
  • the analysis of high intensity natural sweetener in the product created in this invention can be quantified through steviol glycoside levels using high performance liquid chromatography (HPLC).
  • capsicum oleoresin in the product created in this invention can be quantified through capsaicinoid levels (capsaicin and dihydrocapsaicin) using HPLC or gas chromatography.
  • capsaicinoid levels capsaicin and dihydrocapsaicin
  • Rabbits were assigned to supplementation with no additive (control), 150 ppm of an high intensity artificial sweetener (SW) containing at least 96wt% sodium saccharine, NHDC, and maltodextrin; 360 ppm of a high intensity natural sweetener (SWN) containing at least 70wt% steviosides, ammonium glycyrrhizinate, and maltodextrin; or 4 ppm of capsicum oleoresin (CO) containing at least 6wt% capsaicinoids.
  • SW high intensity artificial sweetener
  • SWN high intensity natural sweetener
  • CO capsicum oleoresin
  • This example is used to illustrate synergy between high intensity natural sweeteners and phytonutrients.
  • Rabbits were assigned to one of 6 dietary treatments: control or supplementation with 180 ppm of SWN of Example 1, 2ppm of CO, or 2 ppm of CO combined with various levels of SWN (23, 90, or 180 ppm) of Example 1.
  • the same enteritis challenge was utilized (rabbits were inoculated with 500 pL containing 5 x 106 CFU/mL of E. Coli inoculum from INRA) and the same parameters were measured as for Example 1.
  • SWN at 180ppm actually increased morbidities (disease symptoms including diarrhea and bloat) during disease challenge (Figure 3).
  • the third example demonstrates the effect of an optimum weight ratio of SWN:CO on rabbit health and performance when supplemented at various doses. Rabbits were assigned to control diets or
  • the fourth example demonstrates the response to calves when supplemented with a diet containing a combination of SWN and CO on intestinal health of calves.
  • Calves were assigned to control diets or diets containing 26 ppm SWN of Example 1 and 2 ppm CO.
  • the supplementation decreased the number of pens treated with electrolytes or antibiotics (Figure 7); results illustrate sensitivity of calves to the low dose of supplements fed in combination.
  • the fifth example demonstrates the effect of a combination of SWN and CO on zootechnical performance of piglets.
  • Piglets were assigned to control diets or supplementation with the 30 ppm SWN of Example 1 and 2 ppm CO.
  • the supplementation increased daily gain and final body weight (Figure 8); results illustrate sensitivity of swine to the low dose of supplement fed in combination.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)

Abstract

L'invention concerne des additifs alimentaires contenant une association d'un édulcorant de haute intensité et d'oléorésine de capsicum. Plus précisément, l'invention porte sur un additif alimentaire à ajouter à un aliment afin de préparer un aliment final pour mammifères, comprenant une association d'au moins un édulcorant de haute intensité ; et d'oléorésine de capsicum ; le rapport pondéral de l'édulcorant de haute intensité à l'oléorésine de capsicum étant inférieur ou égal à 25:1. L'invention concerne également un aliment final comprenant l'additif alimentaire selon l'invention en une quantité supérieure à zéro et inférieure ou égale à 200 ppm par rapport au poids de l'aliment final total. En outre, l'invention porte sur l'utilisation de l'additif alimentaire ou de l'aliment final selon l'invention pour améliorer des performances zootechniques de mammifères, en particulier de lapins, de porcs et de veaux.
PCT/IB2019/051941 2018-03-15 2019-03-11 Aliments pour l'amélioration de la santé et des performances de mammifères WO2019175739A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP19715223.4A EP3764817A1 (fr) 2018-03-15 2019-03-11 Aliments pour l'amélioration de la santé et des performances de mammifères
CN201980013368.2A CN111867400A (zh) 2018-03-15 2019-03-11 用于改善哺乳动物健康和行为表现的饲料

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP18020101.4 2018-03-15
EP18020101 2018-03-15
EP18020393 2018-08-20
EP18020393.7 2018-08-20
EP18020394.5 2018-08-20
EP18020394 2018-08-20

Publications (1)

Publication Number Publication Date
WO2019175739A1 true WO2019175739A1 (fr) 2019-09-19

Family

ID=66001270

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2019/051941 WO2019175739A1 (fr) 2018-03-15 2019-03-11 Aliments pour l'amélioration de la santé et des performances de mammifères

Country Status (3)

Country Link
EP (1) EP3764817A1 (fr)
CN (1) CN111867400A (fr)
WO (1) WO2019175739A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115886231A (zh) * 2022-11-19 2023-04-04 浙江华康药业股份有限公司 预防缓解糖醇不耐受的甜味剂组合物及其制备方法
CN116406742A (zh) * 2023-03-06 2023-07-11 中国科学院亚热带农业生态研究所 一种提高肉羊秸秆型日粮采食量和增重的饲料添加剂及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062368A2 (fr) 2006-11-21 2008-05-29 Axiss France S.A.S. Capsicum microencapsule, procede pour sa preparation, et utilisation
FR2926440A1 (fr) * 2008-01-23 2009-07-24 Pancosma Sa Pour L Ind Des Pro Additif alimentaire a base de capsicum et utilisations
WO2012107832A1 (fr) * 2011-02-11 2012-08-16 Pancosma S.A. Utilisation d'un additif comprenant au moins un édulcorant dans l'alimentation et/ou l'eau de boisson avicole(s)
WO2014033218A1 (fr) 2012-08-30 2014-03-06 Pancosma Sa Utilisation d'un édulcorant intense en tant qu'additif alimentaire
FR3043890A1 (fr) * 2015-11-25 2017-05-26 Pancosma Sa Procede d'amelioration des performances zootechniques d'un ruminant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3220750T (pt) * 2014-11-19 2020-06-25 Kalmarna Ltd Composição de reidratação oral e métodos da mesma

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008062368A2 (fr) 2006-11-21 2008-05-29 Axiss France S.A.S. Capsicum microencapsule, procede pour sa preparation, et utilisation
EP2088871A2 (fr) 2006-11-21 2009-08-19 Axiss France S.A.S. Capsicum microencapsule, procede pour sa preparation, et utilisation
US20100055253A1 (en) 2006-11-21 2010-03-04 Axiss France S.A.S. Micro-encapsulated capsicum, method for preparing the same and use thereof
FR2926440A1 (fr) * 2008-01-23 2009-07-24 Pancosma Sa Pour L Ind Des Pro Additif alimentaire a base de capsicum et utilisations
WO2012107832A1 (fr) * 2011-02-11 2012-08-16 Pancosma S.A. Utilisation d'un additif comprenant au moins un édulcorant dans l'alimentation et/ou l'eau de boisson avicole(s)
WO2014033218A1 (fr) 2012-08-30 2014-03-06 Pancosma Sa Utilisation d'un édulcorant intense en tant qu'additif alimentaire
FR3043890A1 (fr) * 2015-11-25 2017-05-26 Pancosma Sa Procede d'amelioration des performances zootechniques d'un ruminant

Non-Patent Citations (22)

* Cited by examiner, † Cited by third party
Title
AGHAJANYAN ET AL., BIOMED RES INT. 2017, 2017, pages 9251358
ANUSH AGHAJANYAN ET AL: "Antihyperglycemic and Antihyperlipidemic Activity of Hydroponic Stevia rebaudiana Aqueous Extract in Hyperglycemia Induced by Immobilization Stress in Rabbits", BIOMED RESEARCH INTERNATIONAL, vol. 2017, 1 January 2017 (2017-01-01), pages 1 - 6, XP055523578, ISSN: 2314-6133, DOI: 10.1155/2017/9251358 *
C H PONCE ET AL: "Effects of a dietary sweetener on growth performance and health of stressed beef calves and on diet digestibility and plasma and urinary metabolite concentrations of healthy calves 1 INTRODUCTION", AMERICAN SOCIETY OF ANIMAL SCIENCE J. ANIM. SCI, 1 January 2014 (2014-01-01), pages 1630 - 1638, XP055585941, Retrieved from the Internet <URL:https://pdfs.semanticscholar.org/ad42/4c384763e394cc061313c0b1541201db2ace.pdf> DOI: 10.2527/jas2013-6795 *
C. IONESCU ET AL: "1743 Supplementation with a blend of capsicum and artificial sweetener improves performance of growing and finishing pigs", JOURNAL OF ANIMAL SCIENCE, vol. 94, no. suppl_5, 1 October 2016 (2016-10-01), US, pages 849 - 849, XP055523220, ISSN: 0021-8812, DOI: 10.2527/jam2016-1743 *
CONNOR ET AL., DOMEST ANIM ENDOCRINOL., vol. 56, no. S56-65, 2016
CONNOR ET AL., J DAIRY SCI., vol. 100, 2017, pages 3004 - 3018
DOUGNON; GBEASSOR, VET WORLD., vol. 9, 2016, pages 281 - 286
KARADAS ET AL., BR POULT SCI., vol. 55, 2014, pages 329 - 334
LEE ET AL., BR J NUTR., vol. 110, 2013, pages 840 - 847
LIU ET AL., J ANIM SCI., vol. 90, 2012, pages 2774 - 2783
LIU ET AL., J ANIM SCI., vol. 91, 2013, pages 5294 - 5306
LIU ET AL., J ANIM SCI., vol. 91, 2013, pages 5668 - 5679
LIU ET AL., J ANIM SCI., vol. 92, 2014, pages 2050 - 2062
LIU ET AL., J ANIM SCI., vol. 92, 2014, pages 3426 - 3440
MORAN ET AL., BR J NUTR., vol. 104, 2010, pages 637 - 646
MORAN ET AL., J DAIRY SCI., vol. 97, 2014, pages 4955 - 4972
PONCE ET AL., J ANIM SCI., vol. 92, 2014, pages 1630 - 1638
QI YU ET AL: "Expression of TRPV1 in rabbits and consuming hot pepper affects its body weight", MOLECULAR BIOLOGY REPORTS ; AN INTERNATIONAL JOURNAL ON MOLECULAR AND CELLULAR BIOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 39, no. 7, 11 February 2012 (2012-02-11), pages 7583 - 7589, XP035059620, ISSN: 1573-4978, DOI: 10.1007/S11033-012-1592-1 *
ROBERT RHOADS ET AL: "Dietary Supplementation of saccharin-based artificial sweeteners and capsicum oleoresin as a strategy to migrate the negative consequences of heat stress on pig growth performance and intestinal physiology", 1 January 2017 (2017-01-01), pages 1 - 105, XP055523223, Retrieved from the Internet <URL:https://vtechworks.lib.vt.edu/bitstream/handle/10919/78279/Biggs_ME_T_2017.pdf?sequence=1&isAllowed=y> [retrieved on 20181113] *
SIURANA ET AL., J. DAIRY SCI., vol. 97, no. 1, 2014, pages 811
TOSSOU JACQUES DOUGNON ET AL: "Evaluation of the effects of the powder of Capsicum frutescens on glycemia in growing rabbits", VETERINARY WORLD, vol. 9, no. 3, 1 March 2016 (2016-03-01), India, pages 281 - 286, XP055523421, ISSN: 0972-8988, DOI: 10.14202/vetworld.2016.281-286 *
YU ET AL., MOL BIOL REP., vol. 39, 2012, pages 7583 - 7589

Also Published As

Publication number Publication date
CN111867400A (zh) 2020-10-30
EP3764817A1 (fr) 2021-01-20

Similar Documents

Publication Publication Date Title
Reddy et al. Plant secondary metabolites as feed additives in calves for antimicrobial stewardship
Omonijo et al. Essential oils as alternatives to antibiotics in swine production
Díaz Carrasco et al. Use of plant extracts as an effective manner to control Clostridium perfringens induced necrotic enteritis in poultry
US8043633B2 (en) Methods and compositions for controlling microorganism populations in the digestive system of animals
Steiner et al. Phytogenic feed additives in animal nutrition
Alagawany et al. The applications of and its derivatives in human, ruminant and fish nutrition–a review
Bozkurt et al. Effects of selected herbs and essential oils on performance, egg quality and some metabolic activities in laying hens-a review.
KR101345366B1 (ko) 울금 추출물, 및 스테비아 추출물 또는 스테비오사이드의 혼합물을 유효성분으로 포함하는 흰점 증후군 바이러스에 대한 내성 증강용 사료 첨가제 조성물 및 이를 포함하는 사료 조성물
WO2019175739A1 (fr) Aliments pour l&#39;amélioration de la santé et des performances de mammifères
Giannenas et al. The effectiveness of the use of oregano and laurel essential oils in chicken feeding
Amar et al. Dietary Onion or Ginger Modulates the Stress Response and Susceptibility to Vibrio harveyi JML 1 Infection in Brown‐marbled Grouper Epinephelus fuscoguttatus Juveniles
Matté et al. Essential oils and essential oil compounds in animal production as antimicrobials and anthelmintics: an updated review
Yasodha et al. Growth performance parameters of broiler chickens as influenced by herbal poultry feed
Gherescu et al. The Influence of Some Phyto-Additives on Bio-Productive Performances and the Health of the Farmed Fish–Review
Jacob et al. Gut Health and Organic Acids, Antimicrobial Peptides, and Botanicals as Natural Feed Additives
Haque et al. Pathogenesis of Gizzard Erosion and Ulcerations and Comprehensive Control Strategy in Poultry
Heidari et al. The effect of adding Stevia (Stevia rebaudian) extract in the diet on the growth, survival and fillet chemical properties on common carp (Cyprinus carpio)
US20230413879A1 (en) Food comprising isosteviol and uses thereof
US9516892B2 (en) Use in ruminants of a food additive including a sweetener
Ahmad et al. IMPACT OF ANTIBIOTIC GROWTH PROMOTERS (AGPS) IN POULTRY PRODUCTION AND ALTERNATIVE STRATEGIES
Ke et al. Study on feeding value evaluation of by-products of sea buckthorn andantibacterial effect of its extracts.
Hengl et al. Enhancing the productive performances and broiler meat quality by phytogens
Sattanathan et al. Growth, feed efficiency, liver biomarkers, antioxidants, hematological indices, immune gene expression, and immunomodulatory effect of Mesosphaerum suaveolens leaf extract in grass carp (Ctenopharyngodon idellus) against Aeromonas hydrophila
Sheela et al. ROLE OF PHYTOCHEMICAL ON HOST PATHOGEN INTERACTIONS-A COMPREHENSIVE REVISION
KR20230135466A (ko) 화합물 c 및 클로로퀸을 유효성분으로 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19715223

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2019715223

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2019715223

Country of ref document: EP

Effective date: 20201015